Forasartan
Overview[edit]
Forasartan is a pharmaceutical compound that belongs to the class of angiotensin II receptor antagonists, commonly known as angiotensin receptor blockers (ARBs). These medications are primarily used in the management of hypertension (high blood pressure) and are also beneficial in treating certain types of heart failure.
Mechanism of Action[edit]
Forasartan works by selectively blocking the binding of angiotensin II to the angiotensin II receptor type 1 (AT1 receptor) in various tissues, including the vascular smooth muscle, adrenal gland, and kidney. This inhibition prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation, reduced blood pressure, and decreased workload on the heart.
Pharmacokinetics[edit]
Forasartan is administered orally and is well absorbed from the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily in the urine and feces. The drug has a relatively long half-life, allowing for once-daily dosing in most patients.
Clinical Uses[edit]
Forasartan is indicated for the treatment of:
- Hypertension: It helps in lowering blood pressure and reducing the risk of cardiovascular events.
- Heart failure: It is used to improve symptoms and reduce mortality in patients with heart failure.
- Diabetic nephropathy: It can slow the progression of kidney disease in patients with type 2 diabetes and hypertension.
Side Effects[edit]
Common side effects of forasartan include:
- Dizziness
- Headache
- Fatigue
- Hyperkalemia (elevated potassium levels)
Less common but serious side effects may include:
Contraindications[edit]
Forasartan is contraindicated in patients with:
- Hypersensitivity to the drug or any of its components
- Pregnancy, due to the risk of fetal toxicity
- Severe renal artery stenosis
Drug Interactions[edit]
Forasartan may interact with other medications, such as:
- Nonsteroidal anti-inflammatory drugs (NSAIDs), which can reduce its antihypertensive effect
- Potassium-sparing diuretics and potassium supplements, which can increase the risk of hyperkalemia
Related Pages[edit]

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian